Search

Your search keyword '"Kullberg, Bart-Jan"' showing total 640 results

Search Constraints

Start Over You searched for: Author "Kullberg, Bart-Jan" Remove constraint Author: "Kullberg, Bart-Jan" Search Limiters Full Text Remove constraint Search Limiters: Full Text
640 results on '"Kullberg, Bart-Jan"'

Search Results

1. A comprehensive genetic map of cytokine responses in Lyme borreliosis

4. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

5. Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study

7. P29 Treatment outcomes with rezafungin and caspofungin in people aged 65 years and above with candidaemia and/or invasive candidiasis: integrated analysis of pooled Phase 2 and Phase 3 data

9. Towards personalized medicine: a scoping review of immunotherapy in sepsis.

11. Correction to “Prevalence of persistent symptoms after treatment for lyme borreliosis: a prospective observational cohort study”

12. Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project

13. 231. Outcomes by Baseline Pathogen and Susceptibility in the ReSTORE Phase 3 Trial of Rezafungin Once Weekly Compared with Caspofungin Once Daily in Patients with Candidemia and/or Invasive Candidiasis

14. Human TLR10 is an anti-inflammatory pattern-recognition receptor

15. Identifying platelet-derived factors as amplifiers ofB. burgdorferi-induced cytokine production

16. Serological and Clinical one year follow-up of Patients with Erythema migrans treated in a Romanian Infectious Disease Hospital

18. Borrelia burgdorferi Is a Poor Inducer of Gamma Interferon: Amplification Induced by Interleukin-12

20. Risk of candidiasis associated with interleukin-17 inhibitors: A real-world observational study of multiple independent sources

22. Ocular Manifestations of Candidemia

31. Functional and Genetic Evidence That the Mal/TIRAP Allele Variant 180L Has Been Selected by Providing Protection against Septic Shock

34. Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria

35. Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

36. Immune Recognition of Candida albicans β-Glucan by Dectin-1

37. TLR4 Polymorphisms, Infectious Diseases, and Evolutionary Pressure during Migration of Modern Humans

40. Identifying platelet-derived factors as amplifiers of B. burgdorferi-induced cytokine production.

41. C[X.sub.3]CR1-dependent renal macrophage survival promotes Candida control and host survival

43. The Inflammasome-Mediated Caspase-1 Activation Controls Adipocyte Differentiation and Insulin Sensitivity

46. Reply

49. Prevalence of persistent symptoms after treatment for lyme borreliosis: A prospective observational cohort study

50. Role of Fas/FasL in Systemic Candidiasis

Catalog

Books, media, physical & digital resources